Home Industry
Industry
Sign up for free Industry Newsletter
Keep up to date with the latest business & market news on microbiome space with our free newsletter.
Industry
Welin Berger: ‘This is how we work on probiotics at Biogaia’
Katayoun Welin Berger, BioGaia's Vice President Operations, tells us about the activities of the company.
Industry
Emily Hollister: ‘From microbiome to therapeutics and diagnostics’
The microbiome may be a source for biomarkers leading to therapeutic discoveries and diagnostics. We discuss it with Emily Hollister, Vice President of Diversigen.
Industry
Richard Ellis: ‘Bringing probiotics from the lab to the market’
Richard Ellis, Head of Business Development at Biose, explains how CDMO companies assist start-ups in bringing live biotherapeutic products to the market.
Dermatology
Travis Whitfill: ‘We’re studying new products for skin diseases’
Travis Whitfill, Co-Founder and CSO of Azitra, explains how Staphylococcus epidermidis-based products may treat various skin conditions and diseases.
Industry
Denise Kelly: ‘2019 will be a very important year for the global microbiome market’
Probiotics: 2019 will be crucial for scientific and regulatory aspects with help coming also from Venture Capital. Denise Kelly from Seventure talks about it.
Industry
Regulation of probiotics: challenges and opportunities
The development of probiotics presents major regulatory challenges. We discussed it this Clara Desvignes from Voisin Consulting Life Sciences.
Industry
Ross Youngs: ‘We investigate the aquatic microbiome to obtain metabolites and postbiotics’
New technologies such as the analysis of the "aquatic microbiota" allow to dig deeply into the microbiome chemistry. We discuss this approach with Ross Youngs, CEO of Biosortia.
Stay in Touch
MicrobiomePost supports the microbiome community by connecting business, investors, academy, industry and science key opinion leaders.
Read more
Food dyes metabolized by gut microbes cause colitis in mice with dysregulated immune system
Specific food dyes are environmental risk factors for colitis development in conditions where IL-23 expression is dysregulated.
Infants’ gut microbiotas harbor hundreds of antibiotic-resistance genes
A new study published in Cell Host & Microbe claims that the infant gut is home to bacteria that harbor hundreds of antibiotic-resistance genes.
Romano Marabelli – Probiotics Prebiotics & New Foods 2021
Advisor to the Director General Romano Marabelli presents the role of the World Organisation for Animal Health at this year's Probiotics, Prebiotics & New Foods...
People at risk for rheumatoid arthritis have unique viral communities in their guts
A new study published in Cell Host & Microbe could pave the way for using phages as biomarkers for the condition of rheumatoid arthritis.